1-4 of 4
Naomi B. Haas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B013: T cell clonotype expansion is common in advanced renal cell carcinoma but is not associated with altered response to PD-1 blockade

Free
Miya B. Hugaboom, Neil Ruthen, Opeyemi Jegede, Nicholas R. Schindler, Lena Wirth, Sasha Kyrysyuk, David F. McDermott, Elizabeth R. Plimack, Jeffrey A. Sosman, Naomi B. Haas, Michael E. Hurwitz, Hans J. Hammers, Sabina Signoretti, Michael B. Atkins, Catherine J. Wu, David A. Braun, Kelly Street
Journal: Cancer Research
Cancer Res (2023) 83 (16_Supplement): B013.
https://doi.org/10.1158/1538-7445.KIDNEY23-B013
Published: 15 August 2023
View articletitled, Abstract B013: T cell clonotype expansion is common in advanced renal cell carcinoma but is not associated with altered response to PD-1 blockade
Journal Articles

Abstract 758: Capture and characterization of circulating tumor cell clusters in patients with metastatic castrate-resistant prostate cancer

Free
Samantha L. Savitch, Stephanie S. Yee, Devon Soucier, Denis Smirnov, Chandra Rao, Steve Gross, Ravi K. Amaravadi, David J. Vaughn, Naomi B. Haas, Erica L. Carpenter
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 758.
https://doi.org/10.1158/1538-7445.AM2017-758
Published: 01 July 2017
View articletitled, Abstract 758: Capture and characterization of circulating tumor cell clusters in patients with metastatic castrate-resistant prostate cancer
Journal Articles

Abstract CT340: Phase 1b/2a study of the nanopharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC): results from the planned interim analysis

Free
Stephen M. Keefe, Meliessa Hennessy, Orvar Gunnarsson, Ronac Mamtani, David Vaughn, Jean Hoffman-Censits, Katherine Nathanson, Priti Lal, Priti Lal, Daniel Pryma, Scott Eliasof, Edward Garmey, Roger B. Cohen, Naomi B. Haas
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT340.
https://doi.org/10.1158/1538-7445.AM2014-CT340
Published: 01 October 2014
View articletitled, Abstract CT340: Phase 1b/2a study of the nanopharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC): results from the planned interim analysis
Journal Articles

Phase I/Pharmacokinetic Study of Topotecan by 24-Hour Continuous Infusion Weekly

Free
Naomi B. Haas, Frank P. LaCreta, Judy Walczak, Gary R. Hudes, James M. Brennan, Robert F. Ozols, Peter J. O'Dwyer
Journal: Cancer Research
Cancer Res (1994) 54 (5): 1220–1226.
Published: 01 March 1994
View articletitled, Phase I/Pharmacokinetic Study of Topotecan by 24-Hour Continuous Infusion Weekly
Open the PDF for Phase I/Pharmacokinetic Study of Topotecan by 24-Hour Continuous Infusion Weekly in another window